Priyanka Shukla

Title: Innovations of Priyanka Shukla in Hepatitis E Research

Introduction

Priyanka Shukla is a notable inventor based in Mumbai, India. She has made significant contributions to the field of virology, particularly in the study of hepatitis E virus (HEV). With two patents to her name, her work has implications for vaccine development and cell culture technologies.

Latest Patents

Priyanka's latest patents focus on the infectious hepatitis E virus genotype 3 recombinants. The inventions relate to the discovery of an HEV strain from a chronically infected patient. This strain grows unusually well in various cell cultures, leading to the development of cell cultures, vectors, and vaccine compositions based on the virus. The identification of a new strain of HEV genotype 3 virus, known as Strain Kernow-C1, was pivotal in her research. This strain was isolated from a chronically infected patient and was used to identify human, pig, and deer cell lines that are permissive for infection. The adaptation of the Kernow-C1 strain to growth in human hepatoma cells resulted in a rare virus recombinant that contains an insertion of 174 ribonucleotides of a human ribosomal protein gene along with additional mutations.

Career Highlights

Throughout her career, Priyanka has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the Royal Cornwall Hospital Trust. Her experience in these institutions has enriched her research and innovation capabilities.

Collaborations

Priyanka has collaborated with notable colleagues, including Suzanne U Emerson and Hanh T Nguyen. These collaborations have furthered her research efforts and contributed to advancements in the understanding of hepatitis E.

Conclusion

Priyanka Shukla's innovative work in hepatitis E research exemplifies her dedication to advancing medical science. Her patents and collaborations highlight her significant contributions to the field.